Circulating tumor DNA as markers of dynamic recurrence risk and adjuvant chemotherapy benefit in resected non-small cell lung cancer.Wei Guo, Shugeng Gao, Yang Xu et al.|Journal of Clinical Oncology|2021Cited by 2